TrialX
Image

TPIV100 and Sargramostim for the Treatment of HER2 Positive Stage II-III Breast Cancer in Patients With Residual Disease After Chemotherapy and Surgery

Testing a new tool for children's allergy control.

Recruiting
1 years and older
Male
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)
Study Purpose: This research aims to explore the effects of an investigational medication and sargramostim on HER2 Positive Stage II-III Breast Cancer in patients who have remaining disease after chemotherapy and surgery. HER2 is a protein that can promote the growth of cancer cells.
Participation Details: Participants will be involved in the study for a certain period, involving multiple visits to the study site. The exact number of visits and length of study are to be discussed with the research team.
Eligibility: You may qualify if you have HER2 Positive Stage II-III Breast Cancer with residual disease after receiving chemotherapy and surgery. Further specific criteria for inclusion and exclusion will be discussed with you by the study team.
  • Commitment: Participation involves multiple visits over the study period.
  • Treatments: You will receive an investigational medication and sargramostim.
  • Age & Condition: Specific criteria apply regarding age and medical condition.
If interested, discuss your eligibility and potential benefits or risks with the research team. Participation is entirely voluntary, and you may withdraw at any time.
Study details
    acne

11 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.